Literature DB >> 8800206

Long-term expression of transforming growth factor TGF beta 1 in mouse skin after localized beta-irradiation.

K Randall1, J E Coggle.   

Abstract

The long-term expression of TGF beta 1 in mouse skin after localized irradiation with a beta-emitting source is reported. The skin of CBA/ca mice was exposed to 50 Gy superficial beta radiation from an 11 mm strontium-90 source. Such a dose produced an acute moist desquamation reaction in 100% of the animals, which was macroscopically resolved within 30 days. The acute response was followed by progressive remodelling of dermal tissues as characterized by histological means. The expression of TGF beta 1 was followed for 12 months after irradiation and showed three distinct waves of expression at the RNA level. Levels of expression initially rose to 230% above controls at 6 h before returning to control levels around 24-48 h. Expression then rose again to 169 and 234% above controls at 14 and 28 days post-irradiation respectively. Levels then declined to those of the controls by 2 months. A progressive increase in expression was then noted after 3 months, which peaked around 9 months and was resolved by 12 months. In a parallel study the skin of 144 CBA/ca mice was exposed to 50 Gy superficial beta radiation from 2 x 4 cm Thulium-170 source and compared with a similar group of sham-irradiated controls. The irradiated group showed a cumulative tumour incidence of 54.3% compared with 0% incidence in the sham-irradiated group. Of the 45 radiation-induced tumours a representative sample of 16 (nine malignant fibrous histiocytomas; three fibrosarcomas; two fibromas; one squamous cell carcinoma; one rhabdomyosarcoma) were selected for further study. Semiquantitative PCR on all these tumours showed elevated levels of TGF beta 1 expression ranging from 1.8 to 87-fold above the levels found in normal skin. This study is part of ongoing investigations into the long-term effects of single accidental exposures. The 50 Gy dose used is comparable with the surface doses obtained by some of the victims of the Chernobyl accident.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8800206     DOI: 10.1080/095530096145085

Source DB:  PubMed          Journal:  Int J Radiat Biol        ISSN: 0955-3002            Impact factor:   2.694


  19 in total

1.  Interference with transforming growth factor-beta/ Smad3 signaling results in accelerated healing of wounds in previously irradiated skin.

Authors:  Kathleen C Flanders; Christopher D Major; Alidad Arabshahi; Ekinadese E Aburime; Miya H Okada; Makiko Fujii; Timothy D Blalock; Gregory S Schultz; Anastasia Sowers; Mario A Anzano; James B Mitchell; Angelo Russo; Anita B Roberts
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

Review 2.  Modifying radiation damage.

Authors:  Kwanghee Kim; William H McBride
Journal:  Curr Drug Targets       Date:  2010-11       Impact factor: 3.465

3.  After the bomb drops: a new look at radiation-induced multiple organ dysfunction syndrome (MODS).

Authors:  Jacqueline P Williams; William H McBride
Journal:  Int J Radiat Biol       Date:  2011-03-21       Impact factor: 2.694

4.  The antioxidant tempol reduces carcinogenesis and enhances survival in mice when administered after nonlethal total body radiation.

Authors:  James B Mitchell; Miriam R Anver; Anastasia L Sowers; Philip S Rosenberg; Maria Figueroa; Angela Thetford; Murali C Krishna; Paul S Albert; John A Cook
Journal:  Cancer Res       Date:  2012-07-17       Impact factor: 12.701

5.  Single Nucleotide Polymorphism TGFβ1 R25P Correlates with Acute Toxicity during Neoadjuvant Chemoradiotherapy in Rectal Cancer Patients.

Authors:  J Joshua Smith; Isaac Wasserman; Sarah A Milgrom; Oliver S Chow; Chin-Tung Chen; Sujata Patil; Karyn A Goodman; Julio Garcia-Aguilar
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-12-18       Impact factor: 7.038

6.  Mice lacking Smad3 are protected against cutaneous injury induced by ionizing radiation.

Authors:  Kathleen C Flanders; Catherine D Sullivan; Makiko Fujii; Anastasia Sowers; Mario A Anzano; Alidad Arabshahi; Christopher Major; Chuxia Deng; Angelo Russo; James B Mitchell; Anita B Roberts
Journal:  Am J Pathol       Date:  2002-03       Impact factor: 4.307

7.  Radiotherapy suppresses angiogenesis in mice through TGF-betaRI/ALK5-dependent inhibition of endothelial cell sprouting.

Authors:  Natsuko Imaizumi; Yan Monnier; Monika Hegi; René-Olivier Mirimanoff; Curzio Rüegg
Journal:  PLoS One       Date:  2010-06-11       Impact factor: 3.240

8.  Halofuginone mediated protection against radiation-induced leg contracture.

Authors:  Hisanari Ishii; Rajani Choudhuri; Askale Mathias; Anastasia L Sowers; Kathleen C Flanders; John A Cook; James B Mitchell
Journal:  Int J Oncol       Date:  2009-08       Impact factor: 5.650

9.  Cellular sources of transforming growth factor-beta isoforms in early and chronic radiation enteropathy.

Authors:  J Wang; H Zheng; C C Sung; K K Richter; M Hauer-Jensen
Journal:  Am J Pathol       Date:  1998-11       Impact factor: 4.307

10.  The TGF-β/Smad repressor TG-interacting factor 1 (TGIF1) plays a role in radiation-induced intestinal injury independently of a Smad signaling pathway.

Authors:  Mohammad Hneino; Agnes François; Valerie Buard; Georges Tarlet; Rym Abderrahmani; Karl Blirando; Pamela A Hoodless; Marc Benderitter; Fabien Milliat
Journal:  PLoS One       Date:  2012-05-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.